TY - JOUR
T1 - Neolithic introgression of IL23R-related protection against chronic inflammatory bowel diseases in modern Europeans
AU - Krause-Kyora, Ben
AU - da Silva, Nicolas Antonio
AU - Kaplan, Elif
AU - Kolbe, Daniel
AU - Schade-Lindig, Sabine
AU - Wahl, Joachim
AU - Berszin, Carola
AU - Francken, Michael
AU - Görner, Irina
AU - Schierhold, Kerstin
AU - Pechtl, Joachim
AU - Grupe, Gisela
AU - Müller, Johannes
AU - Wohlers, Inken
AU - Busch, Hauke
AU - Ellinghaus, David
AU - Caliebe, Amke
AU - Sezgin, Efe
AU - Nebel, Almut
AU - Schreiber, Stefan
N1 - Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.
PY - 2025/3
Y1 - 2025/3
N2 - Background: The hypomorphic variant rs11209026-A in the IL23R gene provides significant protection against immune-related diseases in Europeans, notably inflammatory bowel diseases (IBD). Today, the A-allele occurs with an average frequency of 5% in Europe. Methods: This study comprised 251 ancient genomes from Europe spanning over 14,000 years. In these samples, the investigation focused on admixture-informed analyses and selection scans of rs11209026-A and its haplotypes. Findings: rs11209026-A was found at high frequencies in Anatolian Farmers (AF, 18%). AF later introduced the allele into the ancient European gene-pool. Subsequent admixture caused its frequency to decrease and formed the current southwest-to-northeast allele frequency cline in Europe. The geographic distribution of rs11209026-A may influence the gradient in IBD incidence rates that are highest in northern and eastern Europe. Interpretation: Given the dramatic changes from hunting and gathering to agriculture during the Neolithic, AF might have been exposed to selective pressures from a pro-inflammatory lifestyle and diet. Therefore, the protective A-allele may have increased survival by reducing intestinal inflammation and microbiome dysbiosis. The adaptively evolved function of the variant likely contributes to the high efficacy and low side-effects of modern IL-23 neutralisation therapies for chronic inflammatory diseases. Funding: German Research Foundation (EXC 2167 390884018 and EXC 2150 390870439).
AB - Background: The hypomorphic variant rs11209026-A in the IL23R gene provides significant protection against immune-related diseases in Europeans, notably inflammatory bowel diseases (IBD). Today, the A-allele occurs with an average frequency of 5% in Europe. Methods: This study comprised 251 ancient genomes from Europe spanning over 14,000 years. In these samples, the investigation focused on admixture-informed analyses and selection scans of rs11209026-A and its haplotypes. Findings: rs11209026-A was found at high frequencies in Anatolian Farmers (AF, 18%). AF later introduced the allele into the ancient European gene-pool. Subsequent admixture caused its frequency to decrease and formed the current southwest-to-northeast allele frequency cline in Europe. The geographic distribution of rs11209026-A may influence the gradient in IBD incidence rates that are highest in northern and eastern Europe. Interpretation: Given the dramatic changes from hunting and gathering to agriculture during the Neolithic, AF might have been exposed to selective pressures from a pro-inflammatory lifestyle and diet. Therefore, the protective A-allele may have increased survival by reducing intestinal inflammation and microbiome dysbiosis. The adaptively evolved function of the variant likely contributes to the high efficacy and low side-effects of modern IL-23 neutralisation therapies for chronic inflammatory diseases. Funding: German Research Foundation (EXC 2167 390884018 and EXC 2150 390870439).
UR - http://www.scopus.com/inward/record.url?scp=85217103235&partnerID=8YFLogxK
U2 - 10.1016/j.ebiom.2025.105591
DO - 10.1016/j.ebiom.2025.105591
M3 - Journal articles
C2 - 39923740
AN - SCOPUS:85217103235
SN - 2352-3964
VL - 113
SP - 105591
JO - EBioMedicine
JF - EBioMedicine
M1 - 105591
ER -